Altria (MO) Rally: Dividends, Buybacks, and Risks!
Altria’s (MO) stock shows technical momentum and steady shareholder returns but faces headwinds from weakening cigarette volumes, competitive pressure in nicotine pouches, a recent EPS miss, and regulatory/legal costs. Key drivers this week: Q4 results, a $1.3B impairment, rising RS rating, continued dividend yield (~6.8–7%), and a $2B buyback authorization. Investors should watch pouch market share, FDA actions, and confirmation of the technical breakout.
